Literature DB >> 31720696

[Laryngectomy-still state of the art?]

J M Vahl1, P J Schuler1, J Greve1, S Laban1, A Knopf2, T K Hoffmann3.   

Abstract

Total laryngectomy provides a curative approach for patients with advanced laryngeal and hypopharyngeal cancer without distant metastasis. Especially in stage cT4a disease, laryngectomy is superior to primary radio(chemo)therapy in retrospective studies. Further relevant indications for the procedure are tumor-related laryngeal dysfunction such as dysphagia and aspiration, as well as cancer recurrence after primary radio(chemo)therapy. The surgical procedure is highly standardized, with an appropriate safety profile. The subsequent loss of voice must be compensated by voice rehabilitation (voice prosthesis, ructus). The current overview provides information about indications for laryngectomy, preoperative clinical diagnostics, the surgical procedure, complications, alternative treatment, rehabilitation, and prognosis. Total laryngectomy remains a standard procedure in modern head and neck oncology.

Entities:  

Keywords:  Human papilloma virus; Hypopharyngeal neoplasms; Laryngeal neoplasms; PET-CT; Radiochemotherapy

Mesh:

Year:  2019        PMID: 31720696     DOI: 10.1007/s00106-019-00769-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  98 in total

1.  Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

Authors:  Gregory T Wolf; Susan Gross Fisher; Waun Ki Hong; Robert Hillman; Monica Spaulding; George E Laramore; James W Endicott; Kenneth McClatchey; William G Henderson
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

2.  [Neck dissection-Surgical treatment of cervical lymphatic drainage pathways].

Authors:  J M Vahl; T K Hoffmann
Journal:  HNO       Date:  2019-01       Impact factor: 1.284

Review 3.  Surgical margins in head and neck squamous cell carcinoma: what is 'close'?

Authors:  Matteo Alicandri-Ciufelli; Marco Bonali; Alessia Piccinini; Laura Marra; Angelo Ghidini; Elio Maria Cunsolo; Antonino Maiorana; Livio Presutti; Pier Franco Conte
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-28       Impact factor: 2.503

4.  Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

Authors:  Robert Haddad; Anne O'Neill; Guilherme Rabinowits; Roy Tishler; Fadlo Khuri; Douglas Adkins; Joseph Clark; Nicholas Sarlis; Jochen Lorch; Jonathan J Beitler; Sewanti Limaye; Sarah Riley; Marshall Posner
Journal:  Lancet Oncol       Date:  2013-02-13       Impact factor: 41.316

5.  Utility of abdominal imaging to assess for liver metastasis in patients with head and neck cancer and abnormal liver function tests.

Authors:  Philip G Chen; Stephen S Schoeff; Cara A Watts; James F Reibel; Paul A Levine; David C Shonka; Mark J Jameson
Journal:  Am J Otolaryngol       Date:  2013-10-29       Impact factor: 1.808

6.  Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.

Authors:  Andrew Rosko; Andrew Birkeland; Andrew Shuman; Mark Prince; Carol Bradford; Gregory Wolf; Francis Worden; Avraham Eisbruch; Ashok Srinivasan; Ka Kit Wong; Matthew E Spector
Journal:  Head Neck       Date:  2017-02-25       Impact factor: 3.147

7.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Authors:  Susanne-Martina Eschmann; Frank Paulsen; Matthias Reimold; Helmut Dittmann; Stefan Welz; Gerald Reischl; Hans-Juergen Machulla; Roland Bares
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

8.  Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.

Authors:  Jean-Louis Lefebvre; K Kian Ang
Journal:  Head Neck       Date:  2009-04       Impact factor: 3.147

9.  [Quality of life in long-term survivors after laryngectomy].

Authors:  A Minovi; C Nowak; A Marek; S Hansen; S Dazert; D Brors
Journal:  Laryngorhinootologie       Date:  2008-07-16       Impact factor: 1.057

10.  Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

Authors:  Robert L Ferris; George Blumenschein; Jerome Fayette; Joel Guigay; A Dimitrios Colevas; Lisa Licitra; Kevin Harrington; Stefan Kasper; Everett E Vokes; Caroline Even; Francis Worden; Nabil F Saba; Lara C Iglesias Docampo; Robert Haddad; Tamara Rordorf; Naomi Kiyota; Makoto Tahara; Manish Monga; Mark Lynch; William J Geese; Justin Kopit; James W Shaw; Maura L Gillison
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

View more
  1 in total

1.  [Robotics in otorhinolaryngology, head and neck surgery].

Authors:  F Böhm; J Greve; R Riepl; T K Hoffmann; P J Schuler
Journal:  HNO       Date:  2021-07-16       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.